InterVenn Biosciences Adds Alec Ford and Mitch Levine to Board of Directors

May 19, 2026
InterVenn Biosciences has appointed Alec Ford and Mitch Levine to its Board of Directors as the company advances the commercialization of its glycoproteomic diagnostics.

InterVenn Biosciences announced in a press release the appointment of Alec Ford and Mitch Levine to its Board of Directors. The company stated that the new board members will support its focus on advancing the commercialization of glycoproteomic diagnostics.

Alec Ford brings over three decades of experience in genomics, pharmaceuticals, and biotechnology. He currently serves as Chief Executive Officer of Karius, a company specializing in liquid biopsy for infectious diseases, and previously held senior roles at Myriad Genetics, Novartis, Sanofi-Aventis, Nektar Therapeutics, and Pfizer.

Mitch Levine, Chief Executive Officer of Prenostics, has extensive experience in finance and corporate strategy within the biotechnology and diagnostics sectors. He previously led SmartHealth Diagnostics and served as Chief Financial Officer at Oncocyte, where he managed multiple capital raises and acquisitions. Levine also holds board positions at several life sciences companies.

InterVenn applies artificial intelligence to analyze glycoproteins for disease detection and clinical insights. The company aims to bring glycoproteomics into clinical practice across areas such as women's health and oncology.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

05/19
Sanyou Biopharmaceuticals Upgrades AI-STAL Platform for Intelligent Biologics Discovery
05/19
Ultima Genomics Appoints Francisco De La Vega to Lead Germline Genomics
05/19
OMNY Health Expands Data Network and Introduces Oncology Research Suite
05/19
UNC Greensboro Receives $2 Million for NC BioMISSION Workforce Program
05/19
Vortex Imaging Raises $12 Million to Advance Computational Ultrasound System

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like